retatrutide phase 2 nejm 2023 obesity trial jastreboff Among participants 4 to 66 years of age with acquired hypothalamic obesity, setmelanotide, a melanocortin-4 receptor agonist, led to significantly greater reductions in body-mass index and hunger than placebo at 52 weeks This data from Phase 3

At 4mg/week: 78 doses

Literature indicates that GLP-1 RAs exert their benefits partly by delaying gastric emptying, enhancing insulin secretion, and suppressing glucagon release

Consent to receive text messages is not a condition of purchasing any goods or Services

Doctors use semaglutide to help people with heart problems even if they do not have diabetes

Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis

Alcohol use disorder is a brain disorder characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences